Continuing medical education: SSRIs and pregnancy.
作者信息
Andrade Chittaranjan
机构信息
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore 560 029, India.
出版信息
Indian J Psychiatry. 2010 Jan;52(1):83-6. doi: 10.4103/0019-5545.58906.
Abstract
摘要
相似文献
1
Continuing medical education: SSRIs and pregnancy.继续医学教育：选择性5-羟色胺再摄取抑制剂与妊娠
Indian J Psychiatry. 2010 Jan;52(1):83-6. doi: 10.4103/0019-5545.58906.
2
[Responsibility of the director for continuing education in the forming of occupation and work oriented relations in professional continuing education--part-time occupation and interruption of continuing education].主任在职业继续教育中形成职业与工作导向关系方面的继续教育职责——兼职与继续教育中断
Z Arztl Fortbild (Jena). 1977 Dec 15;71(24):1174-7.
3
[Continuous medical education].
G Ital Nefrol. 2004 Jul-Aug;21(4):355-61.
4
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure.与宫内药物暴露相关的母亲抑郁对新生儿结局的影响
Front Pediatr. 2019 Jul 26;7:309. doi: 10.3389/fped.2019.00309. eCollection 2019.
5
Continuing medical education: who needs it?继续医学教育：谁需要它？
Laryngoscope. 1980 Dec;90(12):1975-80. doi: 10.1288/00005537-198012000-00008.
6
Does continuing medical education improve the quality of medical care? A look at the evidence.继续医学教育能提高医疗质量吗？审视相关证据。
J Fam Pract. 1979 Jun;8(6):1171-4.
7
Continuing Medical Education and Continuing Professional Development in the Republic of Armenia: The Evolution of Legislative and Regulatory Frameworks Post Transition.亚美尼亚共和国的继续医学教育与继续职业发展：转型后立法与监管框架的演变
J Eur CME. 2020 Dec 9;10(1):1853338. doi: 10.1080/21614083.2020.1853338.
8
9
Improving continuing medical education and addressing the challenge of instituting reaccreditation.改进继续医学教育并应对实行再认证的挑战。
Br J Gen Pract. 1996 Jan;46(402):43-5.
10
The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder.选择性5-羟色胺再摄取抑制剂在预防重度抑郁症复发中的作用。
Ther Adv Psychopharmacol. 2018 Jan;8(1):49-58. doi: 10.1177/2045125317737264. Epub 2017 Nov 1.
引用本文的文献
1
How to read a research paper: Reading between and beyond the lines.如何阅读研究论文：字里行间的解读
Indian J Psychiatry. 2011 Oct;53(4):362-6. doi: 10.4103/0019-5545.91912.
本文引用的文献
1
Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.孕期接触选择性5-羟色胺再摄取抑制剂与妊娠结局
Arch Pediatr Adolesc Med. 2009 Oct;163(10):949-54. doi: 10.1001/archpediatrics.2009.164.
2
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.孕期使用选择性5-羟色胺再摄取抑制剂与先天性畸形：基于人群的队列研究
BMJ. 2009 Sep 23;339:b3569. doi: 10.1136/bmj.b3569.
3
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.孕期使用5-羟色胺再摄取抑制剂及其他5-羟色胺能/去甲肾上腺素能抗抑郁药的安全性问题：一项综述
Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009.
4
Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur.选择性5-羟色胺再摄取抑制剂是心脏致畸剂吗？对患有持续性心脏杂音的新生儿进行超声心动图筛查。
Birth Defects Res A Clin Mol Teratol. 2009 Oct;85(10):837-41. doi: 10.1002/bdra.20615.
5
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn.抗抑郁药物的使用与新生儿持续性肺动脉高压的风险
Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):246-52. doi: 10.1002/pds.1710.
6
Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy.孕期使用选择性5-羟色胺再摄取抑制剂相关的先天性心脏病
Mayo Clin Proc. 2009;84(1):23-7. doi: 10.4065/84.1.23.
7
Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn.母亲使用选择性5-羟色胺再摄取抑制剂与新生儿持续性肺动脉高压
Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):801-6. doi: 10.1002/pds.1570.
8
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.帕罗西汀与先天性畸形：荟萃分析及潜在混杂因素的考量
Clin Ther. 2007 May;29(5):918-926. doi: 10.1016/j.clinthera.2007.05.003.
9
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.孕期使用选择性5-羟色胺再摄取抑制剂与出生缺陷风险
N Engl J Med. 2007 Jun 28;356(26):2684-92. doi: 10.1056/NEJMoa066584.
10
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.孕早期使用选择性5-羟色胺再摄取抑制剂与出生缺陷风险
N Engl J Med. 2007 Jun 28;356(26):2675-83. doi: 10.1056/NEJMoa067407.
Zotero 插件